Akt activation induced by an antioxidant compound during ischemia-reperfusion

Free Radical Biology and Medicine

Volumn 35, Issue 9, 2003, Pages 1051-1063

  Toth, Ambrus ^a   Halmosi, Robert ^a   Kovacs, Krisztina ^a   Deres, Peter ^a   Kalai, Tamas ^a   Hideg, Kalman ^a   Toth, Kalman ^a   Sumegi, Balazs ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Free radicals; Ischemia reperfusion; Scavenger; Signal transduction

Indexed keywords

2,2,5,5 TETRAMETHYL 2,5 DIHYDRO 1H PYRROL 3 CARBOXAMIDE; 2,2,5,5 TETRAMETHYL N [1 METHYL 2 (2,6 DIMETHYLPHENOXY)ETHYL] 2,5 DIHYDRO 1H PYRROLE 3 CARBOXAMIDE; 2,2,5,5 TETRAMETHYL N [1 METHYL 2 (2,6 DIMETHYLPHENOXY)ETHYL]PYRROLIDINE 3 CARBOXAMIDE; ANTIOXIDANT; CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; H 2693; H0 2; H0 2434; H0 3144; MEXILETINE; N [1 METHYL 2 (2,6 DIMETHYLPHENOXY)ETHYL] N [(2,2,5,5 TETRAMETHYL 2,5 DIHYDRO 1H PYRROL 3 YL)METHYL]AMINE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; LIPID PEROXIDATION; MALE; MOLECULAR MECHANICS; NONHUMAN; OXIDATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS; WESTERN BLOTTING;

EID: 0142231352     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00467-2     Document Type: Article

References (40)

1. Depre C., Taegtmeyer H. Metabolic aspects of programmed cell survival and cell death in the heart. Cardiovasc. Res. 45:2000;538-548.
2. Szabados E., Fischer M.G., Gallyas F. Jr., Kispal G., Sumegi B. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart. Free Radic. Biol. Med. 27:1999;1103-1113.
3. Halmosi R., Berente Z., Osz E., Toth K., Literati-Nagy P., Sumegi B. Effect of poly-ADP-ribose-polymerase inhibitors on the ischemia-reperfusion induced oxidative cardiac injury and mitochondrial metabolism in Langendorff heart perfusion system. Mol. Pharmacol. 59:2001;1497-1505.
4. Halmosi R., Deres P., Toth A., Berente Z., Kalai T., Sumegi B., Hideg K., Toth K. 2,2,5,5-Tetramethylpyrroline-based compounds in prevention of oxyradical-induced myocardial damage. J. Cardiovasc. Pharmacol. 40:2002;854-867.
5. Krishna M.C., DeGraff W., Hankovszky O.H., Sar C.P., Kalai T., Jeko J., Russo A., Mitchell J.B., Hideg K. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J. Med. Chem. 41:1998;3477-3492.
6. Marton Z., Halmosi R., Horvath B., Alexy T., Kesmarky G., Vekasi J., Battyany I., Hideg K., Toth K. Scavenger effect of experimental and clinically used cardiovascular drugs. J. Cardiovasc. Pharmacol. 38:2001;745-753.
7. Li H., Xu K.Y., Zhou L., Kalai T., Zweier J.L., Hideg K., Kuppusamy P. A pyrroline derivative of mexiletine offers marked protection against ischemia/reperfusion-induced myocardial contractile dysfunction. J. Pharmacol. Exp. Ther. 295:2000;563-571.
8. Shankar R.A., Hideg K., Zweier J.L., Kuppusamy P.A. Targeted antioxidant properties of N-[(tetramethyl-3-pyrroline-3-carboxamido)propyl]phtalimide and its nitroxide metabolite in preventing postischemic myocardial injury. J. Pharmacol. Exp. Ther. 292:2000;838-845.
9. Twomey P., Taira J., DeGraff W., Mitchell J.B., Russo A., Krishna M.C., Hankovszky O.H., Frank L., Hideg K. Direct evidence for in vivo nitroxide free radical production from a new antiarrhythmic drug by EPR spectroscopy. Free Radic. Biol. Med. 22:1997;909-916.
10. Monti E., Cova D., Guido E., Morelli R., Oliva C. Protective effect of the nitroxide tempol against the cardiotoxicity of adriamycin. Free Radic. Biol. Med. 21:1996;463-470.
11. Park J.B., Touyz R.M., Chen X., Schiffrin E.L. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 15:2002;78-84.
12. Mockridge J.W., Marber M.S., Heads R.J. Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes. Biochem. Biophys. Res. Commun. 270:2000;947-952.
13. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress signaling for suicide and survival . J. Cell. Physiol. 192:2002;1-15.
14. Scheid M.P., Woodgett J.R. PKB/Akt functional insights from genetic models . Nat. Rev. 2:2001;760-768.
15. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 101:2000;660-667.
16. Romashkova J.A., Makarov S.S. NF-κB is a target of Akt in anti-apoptotic PDGF signaling. Nature. 401:1999;86-90.
17. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase by Akt dependent phosphorylation. Nature. 399:1999;601-605.
18. Gao F., Gao E., Yue T.L., Ohlstein E.H., Lopez B.L., Christopher T.A., Ma X.L. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation . Circulation. 105:2002;1497-1502.
19. Pap M., Cooper G.M. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β signaling pathway. Mol. Cell. Biol. 22:2002;578-586.
20. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
21. Hankovszky O.H., Hideg K., Baldi I., Frank L. New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5- tetramethylpyrrolidine-3-carboxamides. J. Med. Chem. 29:1986;1138-1152.
22. Miles A.M., Bohle D.S., Glassbrenner P.A., Hansert B., Wink D.A., Grisham M.B. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:1996;40-47.
23. Weiss R.H., Flickinger A.G., Rivers W.J., Hardy M.M., Aston K.W., Ryan U.S., Riley D.P. Evaluation of activity of putative superoxide dismutase mimics. Direct analysis by stopped-flow kinetics. J. Biol. Chem. 268:1993;23049-23054.
24. Serbinova E., Khwaja S., Reznick A.Z., Packer L. Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused Langendorff heart. Free Radic. Res. Commun. 17:1992;49-58.
25. Butterfield D.A., Howard B.J., Yatin S., Allen K.L., Carney J.M. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. USA. 94:1997;674-678.
26. Piacentini L., Karliner J.S. Altered gene expression during hypoxia and reoxygenation of the heart. Pharmacol. Ther. 83:1999;21-37.
27. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling a hard Akt to follow . Trends Biochem. Sci. 26:2001;657-664.
28. Madge L.A., Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells. J. Biol. Chem. 275:2000;15458-15465.
29. Miao W., Luo Z., Kitsis R.N., Walsh K. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J. Mol. Cell. Cardiol. 32:2000;2397-2402.
30. Hong F., Kwon S.J., Jhun B.S., Kim S.S., Ha J., Kim S.J., Sohn N.W., Kang C., Kang I. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci. 68:2001;1095-1105.
31. Klotz L.O., Schieke S.M., Sies H., Holbrook N.J. Peroxynitrite activates the phosphoinositide-3-kinase/Akt pathway in human skin primary fibroblasts. Biochem. J. 352:2000;219-225.
32. Yamashita K., Kajstura J., Discher D.J., Wasserlauf B.J., Bishopric N.H., Anversa P., Webster K.A. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ. Res. 88:2001;609-614.
33. Jonassen A.K., Sack M.N., Mjos O.D., Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ. Res. 89:2001;1191-1198.
34. Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. 2:2001;769-776.
35. Punn A., Mockridge J.W., Farooqui S., Marber M.S., Heads R.J. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem. J. 350:2000;891-899.
36. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 104:2001;330-335.
37. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
38. Yellon D.M., Baxter G.F. Reperfusion injury revisited is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc. Med. 9:1999;245-249.
39. Bijur G.N., De Sarno P., Jope R.S. Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. J. Biol. Chem. 275:2000;7583-7590.
40. Bishopric N.H., Andreka P., Slepak T., Webster K.A. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr. Opin. Pharmacol. 1:2001;141-150.